BIOREGENX, INC. 10-K filing
Filed 2026-04-15 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001683168-26-002975
- Form type
- 10-K
- CIK
- 0001593184
- Primary document
- https://www.sec.gov/Archives/edgar/data/1593184/000168316826002975/bioregenx_i10k-123125.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOREGENX, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $1.9M | - | - |
| Cost Of Revenue | $350,855 | - | - |
| Gross Profit | $1.5M | - | - |
| Operating Income | $-1.2M | - | - |
| Net Income | $-1.5M | - | - |
| Eps Basic | 0 | - | - |
| Eps Diluted | 0 | - | - |
| Total Assets | $410,986 | - | - |
| Total Liabilities | $4.9M | - | - |
| Shareholders Equity | $-4.5M | - | - |
| Operating Cash Flow | $38,972 | - | - |
| Capital Expenditures | $9,057 | - | - |